To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FXYD3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
389 supporting clones for gene FXYD3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU161140 melanotic melanoma, cell line, skin .a 1 to 743 1 to 745 E112K tiling clone, AAA   745/745
(100 %)
8 diff
(99.0 %id)
BQ678488 melanotic melanoma, cell line, skin .b 1 to 756 1 to 759 exact tiling clone, AAA   759/759
(100 %)
4 diff
(99.5 %id)
AA056628 colon, tumor .b 10 to 137 1 to 128       128/128
(100 %)
2 diff
(98.5 %id)
AA056603 colon, tumor .b 311 to 749 442 to 1   tiling clone,   442/443
(99 %)
8 diff
(98.2 %id)
H87316 eye, retina .c 1 to 405 18 to 431   tiling clone,   414/446
(92 %)
26 diff
(94.2 %id)
H87860 eye, retina .c 67 to 428 1 to 364   tiling clone,   364/368
(98 %)
8 diff
(97.9 %id)
AA088825 colon, tumor .c 106 to 481 1 to 384   tiling clone,   384/384
(100 %)
12 diff
(96.9 %id)
H87263 eye, retina .c 604 to 1031 430 to 1   tiling clone,   430/436
(98 %)
5 diff
(98.9 %id)
AA088688 colon, tumor .c 631 to 1053 435 to 12   tiling clone, AAA   424/424
(100 %)
3 diff
(99.3 %id)
H87803 eye, retina .c 692 to 1038 349 to 1   tiling clone,   349/378
(92 %)
11 diff
(97.1 %id)
EL948693 eyeball .d 1 to 529 37 to 561   tiling clone,   525/561
(93 %)
9 diff
(98.4 %id)
NM_001136007.1   .d 199 to 1776 1 to 1578 exact RefSeq, AAA   1578/1578
(100 %)
0 diff
(100 %id)
BQ679734 melanotic melanoma, cell line, skin .d 320 to 958 1 to 639 G131R P139A A142T     639/955
(66 %)
12 diff
(98.8 %id)
BU157560 melanotic melanoma, cell line, skin .d 320 to 1092 1 to 778 Q143X tiling clone,   778/944
(82 %)
22 diff
(97.7 %id)
AA298882 Pancreas .d 402 to 673 1 to 272       272/275
(98 %)
1 diff
(99.7 %id)
AA298900 Pancreas .d 402 to 743 1 to 342       342/351
(97 %)
10 diff
(97.2 %id)
TI_149309891   .d 402 to 1108 800 to 96 V74F I111X AAA   705/928
(75 %)
3 diff
(99.7 %id)
BU688251 lung .d 402 to 1108 723 to 19 V74F I111X tiling clone, AAA   705/714
(98 %)
3 diff
(99.6 %id)
AW959245   .d 403 to 898 1 to 492       492/581
(84 %)
9 diff
(98.5 %id)
CA455693 mixed (pool of 40 RNAs) .e 1 to 490 3 to 493 exact tiling clone,   493/805
(61 %)
10 diff
(98.8 %id)
AA126115 colon, tumor .f 1 to 415 1 to 417   tiling clone,   417/417
(100 %)
2 diff
(99.6 %id)
AA053056 colon, tumor .f 36 to 451 1 to 422   tiling clone,   420/422
(99 %)
8 diff
(98.2 %id)
BX357350 Placenta Cot 25-normalized .f 402 to 1308 947 to 27   tiling clone,   921/947
(97 %)
21 diff
(97.8 %id)
AA126009 colon, tumor .f 1602 to 2032 435 to 1   tiling clone,   435/437
(99 %)
7 diff
(98.4 %id)
AA053399 colon, tumor .f 1623 to 2014 392 to 1   tiling clone,   392/392
(100 %)
1 diff
(99.8 %id)
CA445054 lung, Metastatic Chondrosarcoma .g 1 to 517 536 to 19 I54X tiling clone, AAA   518/527
(98 %)
3 diff
(99.5 %id)
DA454557 tongue, tumor tissue .h 1 to 563 2 to 564 E47K G69S tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
NM_021910.2   .i 1 to 1534 1 to 1534 exact RefSeq, AAA   1534/1534
(100 %)
0 diff
(100 %id)
U28249 lung carcinoma .i 68 to 1534 1 to 1460 S36Q L37V Q38G V39G G40L ... tiling clone,   1460/1460
(100 %)
7 diff
(99.6 %id)
NM_001136012.1   .j 1 to 1450 1 to 1450 exact RefSeq, AAA   1450/1450
(100 %)
0 diff
(100 %id)
AA133749 colon, tumor .j 13 to 411 1 to 398   tiling clone,   398/398
(100 %)
1 diff
(99.8 %id)
H86945 eye, retina .j 22 to 315 1 to 296       294/400
(73 %)
7 diff
(98.3 %id)
AA053747 colon, tumor .j 24 to 394 1 to 371       371/372
(99 %)
1 diff
(99.8 %id)
CB141812 Liver .j 187 to 600 1 to 413 W60C R61T Q66H S81P P82N ...     413/413
(100 %)
9 diff
(97.9 %id)
CB128589 Liver .j 188 to 791 1 to 604 exact     604/604
(100 %)
3 diff
(99.6 %id)
BM740726 Ascites, stomach .j 189 to 739 1 to 551 P99H G100R     551/551
(100 %)
2 diff
(99.7 %id)
BU599719 mixed (pool of 40 RNAs) .j 203 to 781 1 to 579 exact tiling clone,   579/816
(70 %)
5 diff
(99.4 %id)
AA134163 colon, tumor .j 212 to 559 1 to 347   fully sequenced,   338/338
(100 %)
12 diff
(96.5 %id)
BM549935 astrocytoma grade IV, cell line, brain .j 215 to 782 27 to 594 exact AAA   568/594
(95 %)
1 diff
(99.9 %id)
CV569353 cornea, eye .j 215 to 782 1 to 568 exact AAA   568/568
(100 %)
1 diff
(99.9 %id)
AI659507 Prostate .j 246 to 411 166 to 1       166/166
(100 %)
0 diff
(100 %id)
AI940440 colon .j 258 to 367 8 to 116       109/116
(93 %)
8 diff
(93.2 %id)
AA115783 colon, tumor .j 339 to 781 445 to 1       445/454
(98 %)
6 diff
(98.7 %id)
AA983632 adenocarcinoma, colon .j 339 to 784 447 to 3       445/526
(84 %)
16 diff
(97.0 %id)
AI283992 esophagus, squamous cell carcinoma .j 349 to 782 469 to 39   AAA   431/468
(92 %)
22 diff
(95.3 %id)
AI189532 placenta .j 384 to 786 428 to 26   AAA   403/403
(100 %)
15 diff
(96.3 %id)
AA054680 colon, tumor .j 431 to 575 1 to 145       145/145
(100 %)
2 diff
(98.7 %id)
AI880683 colon .j 484 to 782 299 to 1       299/299
(100 %)
1 diff
(99.7 %id)
FN057093 breast carcinoma .j 492 to 554 64 to 1     Submitted on the opposite strand 64/64
(100 %)
1 diff
(98.5 %id)
BI047812 stomach .j 493 to 647 188 to 29       160/192
(83 %)
3 diff
(98.5 %id)
AA640471   .j 493 to 787 2 to 296       295/301
(98 %)
1 diff
(99.7 %id)
BG099524 adenocarcinoma (mucinous component), colon .j 493 to 782 303 to 14   AAA   290/332
(87 %)
1 diff
(99.7 %id)
BE843001 stomach .j 498 to 649 164 to 13       152/164
(92 %)
0 diff
(100 %id)
BF906681 stomach .j 498 to 649 157 to 7     Submitted on the opposite strand 151/157
(96 %)
0 diff
(100 %id)
BI047529 stomach .j 498 to 643 145 to 1       145/145
(100 %)
2 diff
(98.7 %id)
BI047657 stomach .j 498 to 643 147 to 1       147/148
(99 %)
4 diff
(97.3 %id)
AA224985   .j 498 to 782 1 to 285   AAA   285/285
(100 %)
5 diff
(98.3 %id)
AA134164 colon, tumor .j 499 to 775 281 to 1   fully sequenced,   281/281
(100 %)
2 diff
(99.3 %id)
AA228334   .j 500 to 784 1 to 285       285/285
(100 %)
5 diff
(98.3 %id)
AA228423   .j 501 to 782 297 to 16   AAA   282/295
(95 %)
2 diff
(99.4 %id)
AA657793   .j 504 to 560 76 to 5       87/76
(114 %)
44 diff
(42.2 %id)
BG150739 nasopharynx, normal epithelium .j 505 to 752 9 to 257       249/257
(96 %)
10 diff
(96.2 %id)
AI805048 Prostate .j 518 to 782 287 to 23   AAA   265/403
(65 %)
2 diff
(99.6 %id)
AA687568   .j 521 to 784 285 to 22   AAA   264/264
(100 %)
2 diff
(99.3 %id)
AI824690 Prostate .j 529 to 782 275 to 20   AAA   256/269
(95 %)
2 diff
(99.3 %id)
CD521889 pooled .j 530 to 786 1 to 258       258/259
(99 %)
4 diff
(98.5 %id)
BU960019 mixed (pool of 40 RNAs) .j 536 to 786 1 to 251   AAA   251/251
(100 %)
3 diff
(98.9 %id)
AA733207 heart .j 542 to 784 247 to 5       243/247
(98 %)
0 diff
(100 %id)
TI_149313704   .j 560 to 1450 963 to 91   AAA   873/953
(91 %)
24 diff
(97.5 %id)
BF221636 Prostate .j 562 to 782 232 to 12   AAA   221/226
(97 %)
5 diff
(97.8 %id)
AW821696 stomach .j 566 to 788 24 to 245       222/245
(90 %)
6 diff
(97.6 %id)
BE827353 lung_tumor .j 566 to 777 1 to 220       220/220
(100 %)
17 diff
(92.3 %id)
AA904162 carcinoid, lung .j 568 to 781 226 to 15   AAA   212/212
(100 %)
1 diff
(99.6 %id)
EC470348 Prostate .j 574 to 675 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
EC484603 Prostate .j 575 to 675 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
AA133028 colon, tumor .j 612 to 1062 1 to 450       450/451
(99 %)
5 diff
(98.9 %id)
FN089176 breast carcinoma .j 625 to 708 1 to 84       84/85
(98 %)
8 diff
(90.6 %id)
AA229297   .j 625 to 784 178 to 19   AAA   160/160
(100 %)
2 diff
(98.8 %id)
FN096805 breast carcinoma .j 626 to 676 51 to 1     Submitted on the opposite strand 51/52
(98 %)
0 diff
(100 %id)
FN170180 breast carcinoma .j 638 to 724 1 to 87       87/92
(94 %)
4 diff
(95.7 %id)
AW844347 colon_normal .j 684 to 789 1 to 107       107/108
(99 %)
5 diff
(95.4 %id)
H12830 placenta .j 716 to 1197 1 to 496   fully sequenced,   496/496
(100 %)
30 diff
(94.0 %id)
R63014 placenta .j 721 to 1050 7 to 345   fully sequenced,   339/345
(98 %)
13 diff
(96.3 %id)
CB305486 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 726 to 1450 741 to 19   tiling clone, AAA   723/723
(100 %)
6 diff
(99.2 %id)
CB241447 Human Lung Epithelial cells, lung .j 754 to 1450 715 to 19   tiling clone, AAA   697/697
(100 %)
3 diff
(99.6 %id)
AA056436 colon, tumor .j 942 to 1385 454 to 1       454/454
(100 %)
10 diff
(97.8 %id)
AA053583 colon, tumor .j 1001 to 1433 434 to 1       434/434
(100 %)
2 diff
(99.6 %id)
R62960 placenta .j 1020 to 1434 417 to 1   fully sequenced,   417/417
(100 %)
5 diff
(98.9 %id)
AA133642 colon, tumor .j 1022 to 1451 431 to 1       431/431
(100 %)
2 diff
(99.6 %id)
AA132921 colon, tumor .j 1077 to 1433 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
H12776 placenta .j 1167 to 1435 270 to 1   fully sequenced,   270/270
(100 %)
2 diff
(99.3 %id)
NM_001136008.1   .k 1 to 778 1 to 778 exact RefSeq,   778/778
(100 %)
0 diff
(100 %id)
DA890604 rectum .k 160 to 711 2 to 554 G41X L42A I43H C44L A45R ... tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
DR006067 Prostate .k 248 to 861 1 to 614   tiling clone,   614/614
(100 %)
4 diff
(99.4 %id)
BQ332026 lung_tumor .k 451 to 781 326 to 4       323/326
(99 %)
0 diff
(100 %id)
BE566799 bladder, carcinoma, cell line .l 1 to 445 1 to 447 F65L     447/447
(100 %)
5 diff
(98.9 %id)
CA311366 Human Lung Epithelial cells, lung .l 1 to 546 565 to 19 exact tiling clone, AAA   547/556
(98 %)
2 diff
(99.7 %id)
BQ431128 melanotic melanoma, skin .m 1 to 783 1 to 791 exact tiling clone,   791/936
(84 %)
22 diff
(97.7 %id)
CB160176 Liver .m 97 to 666 1 to 570 exact     570/570
(100 %)
0 diff
(100 %id)
NM_005971.3   .m 97 to 1468 1 to 1372 exact RefSeq, AAA   1372/1372
(100 %)
0 diff
(100 %id)
BU859889 adenocarcinoma, cell line, breast .m 101 to 800 1 to 700 G66C AAA   700/700
(100 %)
3 diff
(99.6 %id)
BF978078 melanotic melanoma, high MDR, skin .m 114 to 797 1 to 681 E75R T76L P77H P78L L79S ...     683/681
(100 %)
8 diff
(98.9 %id)
BF692363 melanotic melanoma, high MDR, skin .m 114 to 772 1 to 652 E75R T76L P77H P78L L79S ...     652/792
(82 %)
13 diff
(98.4 %id)
BQ884244 sciatic nerve .m 120 to 941 1 to 838 exact     838/904
(92 %)
24 diff
(97.4 %id)
BP263809 small intestine .m 121 to 691 1 to 572 F11S P29A L79X A85G     572/581
(98 %)
19 diff
(96.8 %id)
BC090044 White Matter pool- 5 brain tissues- femoralartery, olfactory tract, optic tract, cerebellar whitematter, cerebral white matter. .m 148 to 1468 1 to 1321 exact tiling clone, AAA   1321/1321
(100 %)
2 diff
(99.9 %id)
CD558391 White Matter .m 148 to 840 29 to 723 exact     695/881
(78 %)
17 diff
(98.1 %id)
BQ683264 melanotic melanoma, cell line, skin .m 156 to 800 1 to 653 exact AAA   653/653
(100 %)
8 diff
(98.8 %id)
BU731770 eye, RPE and Choroid .m 167 to 799 653 to 19 exact AAA   635/635
(100 %)
3 diff
(99.6 %id)
BG484182 lung .m 232 to 917 1 to 691 E75R T76D P77S P78T L79S ...     691/691
(100 %)
28 diff
(96.0 %id)
CF595439 Stomach, adenocarcinoma .m 239 to 800 1 to 565 exact     565/787
(71 %)
6 diff
(99.3 %id)
BG484935 lung .m 241 to 800 1 to 560 exact AAA   560/560
(100 %)
4 diff
(99.3 %id)
CA943106 Pancreas, Purified pancreatic islet .m 250 to 722 1 to 473 exact     473/473
(100 %)
3 diff
(99.4 %id)
BG546564 lung .m 262 to 920 1 to 656 E75R T76L P77H P78L L79S ...     656/657
(99 %)
6 diff
(99.1 %id)
BE866142 bladder, carcinoma, cell line .m 264 to 810 1 to 545 F65L G66A Q67R K68S S69P ...     545/545
(100 %)
3 diff
(99.5 %id)
CD689259 normal nasopharynx .m 274 to 758 15 to 499 D19N N27S C61R     485/499
(97 %)
10 diff
(98.0 %id)
BU502237 mixed (pool of 40 RNAs) .m 279 to 808 1 to 530 exact     530/556
(95 %)
16 diff
(97.2 %id)
BU565250 mixed (pool of 40 RNAs) .m 280 to 800 1 to 522 exact     522/556
(93 %)
5 diff
(99.2 %id)
CB958871 Pooled-Glandular .m 280 to 797 1 to 518 exact AAA   518/518
(100 %)
8 diff
(98.5 %id)
X93036 breast .m 280 to 788 1 to 509 exact     509/511
(99 %)
1 diff
(99.9 %id)
CB128376 Liver .m 281 to 743 1 to 463 exact     463/463
(100 %)
0 diff
(100 %id)
DA453206 tongue, tumor tissue .m 282 to 699 2 to 420 G40S capped   419/419
(100 %)
5 diff
(98.9 %id)
BF185023 bone marrow, from chronic myelogenous leukemia .m 282 to 775 1 to 494 E75R T76L P77H P78L L79S ...     494/905
(54 %)
10 diff
(98.9 %id)
BF207784 bladder, carcinoma, cell line .m 282 to 798 1 to 516 E75R T76L P77H P78L L79S ... AAA   516/516
(100 %)
3 diff
(99.5 %id)
BF207891 bladder, carcinoma, cell line .m 282 to 800 1 to 529       485/736
(65 %)
29 diff
(96.1 %id)
BF208158 bladder, carcinoma, cell line .m 282 to 802 1 to 523 E75R T76L P77H P78L L79S ...     523/673
(77 %)
8 diff
(98.9 %id)
BF238758 bone marrow, from chronic myelogenous leukemia .m 282 to 798 1 to 517 E75R T76L P77H P78L L79S ... AAA   517/517
(100 %)
4 diff
(99.3 %id)
BF572640 melanotic melanoma, high MDR, skin .m 282 to 716 1 to 435 F11S L12W A13Q G14A P16L ...     435/435
(100 %)
10 diff
(97.8 %id)
BF675313 Prostate .m 282 to 792 1 to 511 E75R T76L P77H P78L L79S ...     511/856
(59 %)
11 diff
(98.8 %id)
BF679756 Prostate .m 282 to 724 1 to 446 F65L G66A Q67R K68S S69P ... AAA   446/545
(81 %)
10 diff
(98.2 %id)
BF681411 Prostate .m 282 to 799 1 to 518 exact AAA   518/518
(100 %)
1 diff
(99.9 %id)
BG494937 lung, mucoepidermoid carcinoma .m 282 to 799 1 to 518 E75R T76L P77H P78L L79S ... AAA   518/518
(100 %)
6 diff
(98.9 %id)
CB856988 anterior tongue, pooled .m 282 to 798 1 to 517 exact     517/517
(100 %)
1 diff
(99.9 %id)
CB145555 Liver .m 282 to 724 1 to 444 exact     444/444
(100 %)
4 diff
(99.1 %id)
BC005238 Bladder, carcinoma .m 283 to 798 1 to 516 exact available from MGC, AAA   516/516
(100 %)
1 diff
(99.9 %id)
BG495226 lung, mucoepidermoid carcinoma .m 283 to 802 1 to 525 exact     525/879
(59 %)
9 diff
(99.0 %id)
CB113225 Liver .m 283 to 802 1 to 520 exact     520/524
(99 %)
1 diff
(99.9 %id)
CB141931 Liver .m 283 to 724 1 to 442 Q2R G74V     442/442
(100 %)
2 diff
(99.6 %id)
BM738783 Ascites, stomach .m 283 to 741 1 to 460 V10C F11V L12P A13G G14R ...     460/460
(100 %)
2 diff
(99.6 %id)
BM788242 Ascites, stomach .m 283 to 795 1 to 513 exact     513/513
(100 %)
0 diff
(100 %id)
BM764603 Ascites, stomach .m 283 to 800 1 to 518 exact AAA   518/518
(100 %)
0 diff
(100 %id)
BM855185 stomach .m 283 to 703 1 to 421 G74E     421/421
(100 %)
1 diff
(99.8 %id)
AW374924 colon .m 284 to 558 12 to 285       274/285
(96 %)
6 diff
(97.9 %id)
BX476026   .m 284 to 798 1 to 515 exact AAA   515/515
(100 %)
0 diff
(100 %id)
BM837620 Ascites, stomach .m 284 to 800 1 to 517 exact AAA   517/517
(100 %)
0 diff
(100 %id)
BM768594 stomach .m 284 to 788 1 to 505 exact     505/505
(100 %)
0 diff
(100 %id)
BM768939 stomach .m 284 to 779 1 to 496 exact     496/496
(100 %)
1 diff
(99.8 %id)
CD708242 normal nasopharynx .m 285 to 646 24 to 385 exact     362/385
(94 %)
7 diff
(98.2 %id)
DA452569 tongue, tumor tissue .m 285 to 840 2 to 557 G40S capped   556/556
(100 %)
2 diff
(99.7 %id)
DA425898 colon .m 286 to 800 2 to 518 exact capped   517/517
(100 %)
2 diff
(99.7 %id)
CF123675 CNCAP(3)T-225 cell line, Prostate .m 288 to 798 39 to 550 exact     512/550
(93 %)
6 diff
(99.0 %id)
BM856416 stomach .m 288 to 797 1 to 510 exact     510/510
(100 %)
0 diff
(100 %id)
TI_154183742   .m 288 to 801 101 to 615 exact     515/550
(93 %)
7 diff
(98.8 %id)
BU675774 lung, Primary Lung Epithelial Cells .m 288 to 800 13 to 526 exact AAA Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
TI_57178566   .m 289 to 804 26 to 540 E75R T76L P77H P78L L79S ... AAA   515/540
(95 %)
8 diff
(98.6 %id)
BM855809 stomach .m 289 to 554 1 to 267       260/269
(96 %)
28 diff
(89.6 %id)
BG961503 colon .m 290 to 697 9 to 416 L9V     408/416
(98 %)
8 diff
(98.1 %id)
AA176979   .m 290 to 800 1 to 509 exact AAA   509/509
(100 %)
7 diff
(98.7 %id)
EL945965 eyeball .m 291 to 758 62 to 529 exact     468/529
(88 %)
6 diff
(98.9 %id)
TI_57148808   .m 291 to 797 23 to 526 L6G G7A L8C V10C F11S ... AAA   504/526
(95 %)
10 diff
(98.1 %id)
TI_57234812   .m 291 to 800 28 to 536 E75R T76L P77H P78L L79S ... AAA   509/536
(94 %)
8 diff
(98.6 %id)
DN995945 breast cancer, Mammary gland (cancer tissue) .m 291 to 800 1 to 510 exact AAA   510/510
(100 %)
4 diff
(99.3 %id)
AI940423 colon .m 292 to 558 1 to 268       268/268
(100 %)
8 diff
(97.1 %id)
BM824188 Ascites, stomach .m 292 to 802 1 to 512 P29I Y31L Y32L D33*     512/513
(99 %)
7 diff
(98.7 %id)
AA298444 placenta .m 293 to 554 1 to 263       263/263
(100 %)
6 diff
(97.8 %id)
AW577819 colon_normal .m 293 to 558 268 to 1       268/268
(100 %)
7 diff
(97.4 %id)
AA297619 gall bladder .m 298 to 535 1 to 238       238/238
(100 %)
0 diff
(100 %id)
AA657901   .m 298 to 667 1 to 371 Q86K S87A     371/371
(100 %)
7 diff
(98.2 %id)
AI144215 heart .m 298 to 800 519 to 17 exact AAA   503/506
(99 %)
2 diff
(99.7 %id)
BI764206 pooled colon, kidney, stomach .m 298 to 797 1 to 497 L6G G7A L8C V10C F11S ... AAA   497/497
(100 %)
4 diff
(99.2 %id)
BI768400 pooled lung and spleen .m 298 to 804 1 to 506 E75R T76L P77H P78L L79S ... AAA   506/506
(100 %)
2 diff
(99.7 %id)
BI907759 leukocyte .m 298 to 800 1 to 502 E75R T76L P77H P78L L79S ... AAA   502/502
(100 %)
2 diff
(99.7 %id)
AW751384 colon .m 299 to 558 1 to 260       260/260
(100 %)
4 diff
(98.5 %id)
BM824275 Ascites, stomach .m 299 to 724 1 to 426 exact     426/426
(100 %)
0 diff
(100 %id)
BG676368 skin, squamous cell carcinoma .m 300 to 1214 1 to 912 E75R T76L P77H P78L L79S ...     912/994
(91 %)
33 diff
(96.7 %id)
AW630833 2 pooled high-grade transitional celltumors, genitourinary tract .m 301 to 695 1 to 395 exact     395/395
(100 %)
0 diff
(100 %id)
BE565351 bladder, carcinoma, cell line .m 301 to 774 1 to 480 G40A L42S I43S C44A A45L ...     480/594
(80 %)
17 diff
(97.2 %id)
BM707557 eye, eye anterior segment .m 301 to 666 9 to 374 exact     366/374
(97 %)
6 diff
(98.4 %id)
BE566407 bladder, carcinoma, cell line .m 302 to 980 1 to 673 G40C C61M K62Q C63M K64Q ...     673/756
(89 %)
46 diff
(94.0 %id)
BF028848 bladder, carcinoma, cell line .m 302 to 800 1 to 498 E75R T76L P77H P78L L79S ... AAA   498/498
(100 %)
3 diff
(99.4 %id)
BF029642 bladder, carcinoma, cell line .m 302 to 802 1 to 503 F15L     503/534
(94 %)
8 diff
(98.6 %id)
BF029693 bladder, carcinoma, cell line .m 302 to 806 1 to 510 Q2H P16L V17S L18W D19T ...     508/573
(88 %)
22 diff
(96.2 %id)
BU185087 adenocarcinoma, Pancreas .m 302 to 798 1 to 497 exact AAA   497/497
(100 %)
0 diff
(100 %id)
BU179637 adenocarcinoma, Pancreas .m 302 to 798 1 to 497 exact AAA   497/497
(100 %)
0 diff
(100 %id)
AW238317 carcinoma in situ from retromolar trigone .m 303 to 647 9 to 353 exact   Submitted on the opposite strand 345/353
(97 %)
6 diff
(98.4 %id)
BE866157 bladder, carcinoma, cell line .m 303 to 801 1 to 496 E75R T76L P77H P78L L79S ... AAA   496/496
(100 %)
6 diff
(98.8 %id)
AA099811 colon, tumor .m 304 to 689 1 to 387 L37S Q38R V39L G40A L42S ...     375/387
(96 %)
17 diff
(95.7 %id)
AA149551 colon, tumor .m 304 to 899 1 to 587 G52X I53S I54S I55S V56S ... fully sequenced,   587/587
(100 %)
14 diff
(97.7 %id)
BU161118 melanotic melanoma, skin .m 304 to 801 1 to 498 exact     498/502
(99 %)
1 diff
(99.9 %id)
BQ300476 bladder_tumor .m 305 to 792 487 to 1 exact     487/487
(100 %)
5 diff
(99.0 %id)
AW629598 2 pooled high-grade transitional celltumors, genitourinary tract .m 305 to 816 1 to 512 exact tiling clone,   512/512
(100 %)
0 diff
(100 %id)
AA308424 colon .m 307 to 692 1 to 386 exact     386/386
(100 %)
0 diff
(100 %id)
AA314125 colon .m 307 to 753 1 to 445 L37S Q38R V39L G40A L42S ...     436/445
(97 %)
11 diff
(97.6 %id)
AA315528 colon .m 307 to 695 1 to 389 D33X K62X     389/389
(100 %)
0 diff
(100 %id)
BI715233 Pancreas, Purified pancreatic islet .m 307 to 800 1 to 494 exact AAA   494/494
(100 %)
0 diff
(100 %id)
BM796231 Ascites, stomach .m 308 to 805 1 to 498 E24K     498/503
(99 %)
4 diff
(99.3 %id)
BE327704 carcinoid, lung .m 309 to 777 8 to 475 exact   Submitted on the opposite strand 468/475
(98 %)
7 diff
(98.6 %id)
AA458611 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 311 to 729 1 to 419 C61R     419/419
(100 %)
3 diff
(99.3 %id)
AA579248   .m 312 to 693 8 to 388 Q86K S87A     381/388
(98 %)
1 diff
(99.8 %id)
BM663551 eye, RPE and Choroid .m 312 to 800 506 to 18 exact AAA   489/489
(100 %)
2 diff
(99.6 %id)
AW238482 carcinoma in situ from retromolar trigone .m 316 to 750 9 to 443 S36G   Submitted on the opposite strand 426/443
(96 %)
11 diff
(97.6 %id)
AW263857 carcinoma in situ from retromolar trigone .m 316 to 742 9 to 435 S36G   Submitted on the opposite strand 418/435
(96 %)
13 diff
(97.1 %id)
AA151921 colon, tumor .m 317 to 801 1 to 481 I53S I54S I55S V56S M57* fully sequenced,   481/481
(100 %)
5 diff
(99.0 %id)
AW081111 colon, moderately differentiated adenocarcinoma .m 317 to 800 500 to 17 P82Q AAA   484/484
(100 %)
1 diff
(99.8 %id)
BE736278 adenocarcinoma, Pancreas .m 317 to 804 1 to 487 E75R T76L P77H P78L L79S ... AAA   487/487
(100 %)
1 diff
(99.8 %id)
AI333205 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 318 to 800 483 to 1 exact     483/483
(100 %)
0 diff
(100 %id)
AW950258   .m 321 to 800 1 to 480 exact AAA   480/480
(100 %)
0 diff
(100 %id)
AI949491 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m 321 to 802 482 to 1 exact     482/482
(100 %)
0 diff
(100 %id)
AI275995 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 322 to 804 483 to 1 exact     483/483
(100 %)
0 diff
(100 %id)
BE793135 lung, small cell carcinoma .m 323 to 805 1 to 484 F15L     484/484
(100 %)
2 diff
(99.6 %id)
AA151715 colon, tumor .m 413 to 800 386 to 1   fully sequenced,   386/386
(100 %)
5 diff
(98.8 %id)
AA149465 colon, tumor .m 893 to 1468 567 to 1   fully sequenced,   567/567
(100 %)
17 diff
(97.1 %id)
AW613184 2 pooled high-grade transitional celltumors, genitourinary tract .m 1119 to 1233 115 to 1       115/115
(100 %)
4 diff
(96.6 %id)
AA100304 colon, tumor .m 1138 to 1403 268 to 1       268/268
(100 %)
2 diff
(99.3 %id)
BQ682674 melanotic melanoma, cell line, skin .n 1 to 911 1 to 909 L8P L9A V10C F11V L12P ... tiling clone,   909/939
(96 %)
34 diff
(96.4 %id)
NM_001136011.1   .n 246 to 1701 1 to 1456 exact RefSeq, AAA   1456/1456
(100 %)
0 diff
(100 %id)
BQ683733 melanotic melanoma, cell line, skin .n 297 to 1154 21 to 880 V4G L9V V10G F11V V17G ...     860/936
(91 %)
71 diff
(92.5 %id)
BU162388 melanotic melanoma, cell line, skin .n 298 to 1162 1 to 878 exact     878/898
(97 %)
27 diff
(97.0 %id)
BQ681687 melanotic melanoma, cell line, skin .n 298 to 986 1 to 694 exact     694/988
(70 %)
18 diff
(98.2 %id)
BQ676323 melanotic melanoma, cell line, skin .n 298 to 1195 1 to 905 exact     905/907
(99 %)
24 diff
(97.4 %id)
BQ683995 melanotic melanoma, cell line, skin .n 298 to 1068 1 to 775 exact     775/925
(83 %)
26 diff
(97.2 %id)
BU174150 melanotic melanoma, cell line, skin .n 298 to 1154 1 to 870 exact     870/903
(96 %)
20 diff
(97.8 %id)
BQ680426 melanotic melanoma, cell line, skin .n 298 to 1099 1 to 819 exact     819/973
(84 %)
35 diff
(96.5 %id)
BQ888731 melanotic melanoma, cell line, skin .n 352 to 1026 1 to 682 F15X S58X A59X     682/809
(84 %)
7 diff
(99.2 %id)
BM838099 Ascites, stomach .n 433 to 1012 1 to 580 exact     580/580
(100 %)
3 diff
(99.5 %id)
CD686647 normal nasopharynx .n 436 to 833 1 to 402       402/402
(100 %)
6 diff
(98.6 %id)
BM978849 lung, Primary Lung Epithelial Cells .n 437 to 827 11 to 401     Submitted on the opposite strand 391/391
(100 %)
3 diff
(99.3 %id)
BU185141 adenocarcinoma, Pancreas .n 443 to 1033 1 to 591 exact AAA   591/591
(100 %)
0 diff
(100 %id)
AA134209 colon, tumor .n 453 to 644 1 to 192       192/391
(49 %)
1 diff
(99.8 %id)
BM996079 lung, Metastatic Chondrosarcoma .n 471 to 1037 579 to 15 A50P AAA   565/568
(99 %)
7 diff
(98.8 %id)
BM795648 stomach .n 502 to 980 1 to 479 exact     479/479
(100 %)
0 diff
(100 %id)
AA826766 epithelium (cell line), Prostate .n 518 to 1026 509 to 1 W34V     509/509
(100 %)
3 diff
(99.5 %id)
BP387389 pancreatic islet .n 538 to 1035 1 to 498 exact   Submitted on the opposite strand 498/500
(99 %)
2 diff
(99.6 %id)
AA296870 adipose tissue, white .n 553 to 819 1 to 272       272/274
(99 %)
11 diff
(96.0 %id)
AW751386 colon .n 556 to 791 10 to 250       241/250
(96 %)
15 diff
(94.0 %id)
AA229119   .n 556 to 824 10 to 277       259/277
(93 %)
16 diff
(94.3 %id)
TI_151742067   .n 559 to 1032 569 to 96 G7A AAA   474/474
(100 %)
3 diff
(99.4 %id)
AA229956   .n 560 to 922 8 to 371 S36T L37S Q38R V39L G40A ...     336/371
(90 %)
33 diff
(91.2 %id)
TI_151767545   .n 560 to 961 252 to 657 V4G G14S E24K     406/792
(51 %)
16 diff
(98.0 %id)
DR422794 eye, Pterygium .n 563 to 1036 1 to 474 exact AAA   474/474
(100 %)
1 diff
(99.8 %id)
BF589534 Prostate .n 568 to 1033 482 to 17 S87X AAA   466/466
(100 %)
2 diff
(99.6 %id)
BE615675 adenocarcinoma, Pancreas .n 569 to 1036 1 to 468 E75R T76L P77H P78L L79S ...     468/754
(62 %)
3 diff
(99.7 %id)
BE616001 adenocarcinoma, Pancreas .n 570 to 984 1 to 416 N21E D22*     416/787
(52 %)
5 diff
(99.4 %id)
BE614718 adenocarcinoma, Pancreas .n 570 to 1036 1 to 467 exact     467/983
(47 %)
1 diff
(99.9 %id)
TI_157612061   .n 570 to 1033 606 to 143 V4L L79F AAA   464/465
(99 %)
9 diff
(98.1 %id)
BT006712   .n 572 to 833 1 to 262       262/264
(99 %)
1 diff
(99.7 %id)
CR456945   .n 572 to 831 1 to 260       260/264
(98 %)
2 diff
(99.3 %id)
CR542197   .n 572 to 832 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
CV027304 mixed .n 572 to 819 1 to 248       248/360
(68 %)
1 diff
(99.8 %id)
AA722520 heart .n 572 to 1035 469 to 6 K3S W34V     464/469
(98 %)
4 diff
(99.2 %id)
AA625834 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 572 to 1033 477 to 17 V4L W34C H35T S36A L37S ... AAA   461/461
(100 %)
4 diff
(99.2 %id)
AA229750   .n 572 to 1035 471 to 8 A13P W34L G83C     464/471
(98 %)
5 diff
(99.0 %id)
AA603808 breast .n 572 to 1019 448 to 1 V4*     448/448
(100 %)
4 diff
(99.2 %id)
AA613908   .n 572 to 1037 478 to 13 exact AAA   466/466
(100 %)
0 diff
(100 %id)
AA652815   .n 572 to 1033 475 to 15 G7R G14A P16L V17S L18W ... AAA   461/461
(100 %)
1 diff
(99.8 %id)
AI138642 heart .n 572 to 1035 469 to 6 exact     464/469
(98 %)
0 diff
(100 %id)
AI378871 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 572 to 1016 478 to 34 exact AAA   445/464
(95 %)
0 diff
(100 %id)
AI383977 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 572 to 830 259 to 1       259/259
(100 %)
1 diff
(99.7 %id)
AI554039 pooled .n 572 to 1035 465 to 1 P16S V17C L18P D19G A20R ...     465/465
(100 %)
4 diff
(99.2 %id)
AI598000 adenocarcinoma, Pancreas .n 572 to 1035 468 to 5 Q2R K26X N27T     464/468
(99 %)
4 diff
(99.2 %id)
AI735022 colon .n 572 to 1035 465 to 2 Q2H L9V L12V L18M D19N ...     464/465
(99 %)
10 diff
(97.9 %id)
AI718916 colon .n 572 to 1033 462 to 1 Q2R N21I     462/462
(100 %)
9 diff
(98.1 %id)
AI826321 normal prostate, Prostate .n 572 to 1032 462 to 2 exact     461/462
(99 %)
1 diff
(99.8 %id)
AW071170 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .n 572 to 1038 471 to 5 Q2K T5P D22A G40S     467/471
(99 %)
5 diff
(99.0 %id)
BG231278 nasopharynx, normal epithelium .n 572 to 1032 484 to 24 F15Y AAA   461/461
(100 %)
1 diff
(99.8 %id)
BG231283 nasopharynx, normal epithelium .n 572 to 1037 482 to 17 D19X AAA   466/466
(100 %)
0 diff
(100 %id)
BQ300443 bladder_tumor .n 573 to 1027 478 to 26       453/478
(94 %)
0 diff
(100 %id)
AA532582 normal prostatic epithelial cells, Prostate .n 574 to 771 1 to 198       198/199
(99 %)
5 diff
(97.5 %id)
AA507667 Prostate .n 575 to 1033 470 to 13   AAA   458/458
(100 %)
6 diff
(98.7 %id)
AI276743 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 575 to 1033 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI983802 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 575 to 1038 465 to 2   tiling clone,   464/465
(99 %)
0 diff
(100 %id)
BF589682 Prostate .n 575 to 754 180 to 1       180/180
(100 %)
0 diff
(100 %id)
AW881919 ovary .n 576 to 840 13 to 278       266/289
(92 %)
12 diff
(95.9 %id)
AA883531 pooled .n 576 to 1019 443 to 1       443/444
(99 %)
21 diff
(95.3 %id)
BM818169 Ascites, stomach .n 577 to 770 1 to 194       194/194
(100 %)
7 diff
(96.4 %id)
AI371056 lung .n 578 to 1032 493 to 39   AAA   455/455
(100 %)
23 diff
(95.0 %id)
AI459599 colon .n 578 to 811 253 to 7       260/259
(100 %)
59 diff
(77.3 %id)
AI445313 colon, moderately-differentiated adenocarcinoma .n 578 to 1033 454 to 1       454/457
(99 %)
6 diff
(98.7 %id)
AI720914 colon .n 579 to 1031 456 to 4       453/456
(99 %)
0 diff
(100 %id)
AW250110 lung, small cell carcinoma .n 580 to 1127 68 to 617       550/617
(89 %)
10 diff
(98.4 %id)
AW880365 ovary .n 581 to 921 60 to 400       341/400
(85 %)
6 diff
(98.5 %id)
AA492169 Prostate .n 581 to 1035 456 to 2       455/456
(99 %)
0 diff
(100 %id)
AW050802 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 584 to 1033 463 to 12   AAA   452/452
(100 %)
4 diff
(99.2 %id)
BU588530 mixed (pool of 40 RNAs) .n 585 to 1035 1 to 451       451/488
(92 %)
4 diff
(99.2 %id)
AA633096 colon, colon tumor RER+ .n 587 to 1028 441 to 1       441/441
(100 %)
4 diff
(99.1 %id)
AI184966 lung .n 588 to 1035 448 to 1       448/449
(99 %)
3 diff
(99.4 %id)
AW768996 colon, moderately-differentiated adenocarcinoma .n 588 to 1035 450 to 2       449/450
(99 %)
4 diff
(99.2 %id)
R81754 placenta .n 589 to 849 15 to 274   fully sequenced,   260/274
(94 %)
7 diff
(97.5 %id)
AI660236 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 589 to 1035 448 to 2       447/448
(99 %)
0 diff
(100 %id)
BI792433 Pancreas, Purified pancreatic islet .n 592 to 1033 442 to 1       442/442
(100 %)
0 diff
(100 %id)
BF755707 colon .n 598 to 879 282 to 1     Submitted on the opposite strand 282/284
(99 %)
8 diff
(97.2 %id)
AA687554   .n 599 to 1033 445 to 12   AAA   434/434
(100 %)
5 diff
(98.9 %id)
R32874 placenta .n 604 to 1033 431 to 1       431/431
(100 %)
4 diff
(99.1 %id)
AI720868 colon .n 604 to 1031 428 to 1       428/428
(100 %)
0 diff
(100 %id)
BF743406 breast .n 610 to 947 14 to 351       338/354
(95 %)
16 diff
(95.5 %id)
AW000761 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 610 to 1032 425 to 2       424/436
(97 %)
4 diff
(99.1 %id)
AI991679 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .n 611 to 1038 432 to 3       430/432
(99 %)
2 diff
(99.6 %id)
AA723360 heart .n 612 to 830 219 to 1       219/226
(96 %)
2 diff
(99.2 %id)
R82346 placenta .n 614 to 1034 426 to 1       426/426
(100 %)
8 diff
(98.2 %id)
AI659937 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 614 to 1033 455 to 36   AAA   420/420
(100 %)
15 diff
(96.5 %id)
AI816729 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .n 614 to 1035 428 to 7       422/428
(98 %)
0 diff
(100 %id)
AI949065 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 621 to 1035 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
CA453306 mixed (pool of 40 RNAs) .n 624 to 1366 1 to 752   tiling clone,   752/793
(94 %)
20 diff
(97.5 %id)
AI860295 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .n 632 to 1033 413 to 12   AAA   402/402
(100 %)
2 diff
(99.6 %id)
BU566347 mixed (pool of 40 RNAs) .n 633 to 1013 1 to 381       381/415
(91 %)
5 diff
(98.8 %id)
BF766842 colon_est .n 637 to 947 28 to 337       310/340
(91 %)
14 diff
(95.9 %id)
AA532561 normal prostatic epithelial cells, Prostate .n 637 to 1005 19 to 386       368/435
(84 %)
13 diff
(97.1 %id)
AI459573 colon .n 637 to 1035 400 to 2       399/404
(98 %)
0 diff
(100 %id)
AA654010 epithelium (cell line), Prostate .n 638 to 1027 389 to 1       389/389
(100 %)
2 diff
(99.5 %id)
AI766410 Kidney .n 644 to 1033 407 to 17   AAA   391/391
(100 %)
2 diff
(99.5 %id)
AA134210 colon, tumor .n 646 to 1026 383 to 1       383/418
(91 %)
11 diff
(97.4 %id)
BQ319157 colon .n 649 to 908 262 to 1       262/262
(100 %)
9 diff
(96.6 %id)
AI183491 heart .n 650 to 1032 413 to 32   AAA   382/382
(100 %)
9 diff
(97.7 %id)
BG231083 nasopharynx, normal epithelium .n 650 to 1031 440 to 59   AAA   382/382
(100 %)
1 diff
(99.8 %id)
AA503659 Prostate .n 651 to 1035 389 to 4       386/432
(89 %)
14 diff
(96.8 %id)
AI424729 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 651 to 1033 385 to 1       385/388
(99 %)
17 diff
(95.7 %id)
AI537580 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 653 to 1037 385 to 1       385/397
(96 %)
19 diff
(95.3 %id)
AA229225   .n 654 to 1035 398 to 19   AAA   380/380
(100 %)
3 diff
(99.3 %id)
H86952.
matches multiple genes
eye, retina .n 657 to 1008 358 to 5     also hits gene spujerby 354/403
(87 %)
10 diff
(97.6 %id)
AA533988 normal prostatic epithelial cells, Prostate .n 657 to 1038 395 to 13       383/510
(75 %)
6 diff
(98.9 %id)
AA229118   .n 657 to 1025 368 to 1       368/414
(88 %)
5 diff
(98.8 %id)
AA229224   .n 657 to 785 9 to 134       126/134
(94 %)
6 diff
(95.6 %id)
AA229276   .n 657 to 787 9 to 137       129/137
(94 %)
6 diff
(95.7 %id)
AA857073 epithelium (cell line), Prostate .n 657 to 1033 408 to 34   AAA   375/406
(92 %)
8 diff
(98.1 %id)
AA878096 pharynx, squamous cell carcinoma .n 657 to 1033 378 to 1       378/435
(86 %)
6 diff
(98.7 %id)
AA862103 squamous cell carcinoma from base of tongue, tongue .n 657 to 1026 370 to 1       370/447
(82 %)
6 diff
(98.7 %id)
DR422509 eye, Pterygium .n 657 to 1178 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
BM768612 stomach .n 659 to 960 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
BM856087 stomach .n 659 to 1030 1 to 372       372/372
(100 %)
1 diff
(99.8 %id)
H12476 placenta .n 668 to 1019 362 to 1       362/372
(97 %)
22 diff
(94.1 %id)
AA653710 normal prostate, Prostate .n 668 to 1035 370 to 5       366/448
(81 %)
10 diff
(97.8 %id)
AW084534 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 668 to 1033 406 to 40   AAA   367/391
(93 %)
32 diff
(91.9 %id)
CA502921 Human Lung Epithelial cells, lung .n 668 to 1037 388 to 19   AAA   370/382
(96 %)
1 diff
(99.8 %id)
AI581859 colon .n 671 to 1037 380 to 14   AAA   367/367
(100 %)
3 diff
(99.2 %id)
AI687995 pooled .n 673 to 1039 366 to 1       366/366
(100 %)
10 diff
(97.3 %id)
AA135122 colon, tumor .n 682 to 1026 344 to 1       344/425
(80 %)
2 diff
(99.6 %id)
AI282690 colon, moderately-differentiated adenocarcinoma .n 683 to 1038 361 to 6       356/361
(98 %)
0 diff
(100 %id)
AA613779   .n 684 to 868 1 to 185       185/185
(100 %)
0 diff
(100 %id)
H64528 nose, olfactory epithelium .n 686 to 1025 353 to 9       345/353
(97 %)
8 diff
(97.8 %id)
BU564729 mixed (pool of 40 RNAs) .n 686 to 1035 1 to 350       350/951
(36 %)
4 diff
(99.6 %id)
BU536003 mixed (pool of 40 RNAs) .n 691 to 1031 1 to 341       341/452
(75 %)
3 diff
(99.4 %id)
BE077402 breast .n 692 to 1001 324 to 14     Submitted on the opposite strand 311/349
(89 %)
3 diff
(99.2 %id)
BE827347 lung_tumor .n 699 to 1028 40 to 373       332/373
(89 %)
19 diff
(95.0 %id)
AI936157 normal prostate, Prostate .n 703 to 1033 342 to 12   AAA   331/331
(100 %)
4 diff
(98.8 %id)
AI240520 pooled .n 731 to 1034 307 to 1       307/307
(100 %)
10 diff
(96.8 %id)
AI720909 colon .n 737 to 1037 301 to 1       301/326
(92 %)
0 diff
(100 %id)
AI720714 colon .n 739 to 1033 295 to 1       295/295
(100 %)
3 diff
(99.0 %id)
R81508 placenta .n 785 to 1020 249 to 12   fully sequenced,   238/249
(95 %)
4 diff
(98.4 %id)
AA143773 colon, tumor .n 1032 to 1636 601 to 1       601/602
(99 %)
17 diff
(97.2 %id)
BF766637 colon_est .n 1072 to 1459 1 to 389       389/389
(100 %)
3 diff
(99.3 %id)
AA152425 colon, tumor .n 1112 to 1409 1 to 300   fully sequenced,   300/300
(100 %)
2 diff
(99.4 %id)
BM853568 Ascites, stomach .n 1126 to 1687 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
BE715894 head_neck .n 1137 to 1537 404 to 3       402/419
(95 %)
0 diff
(100 %id)
BE836338 prostate_normal .n 1137 to 1535 416 to 18       399/422
(94 %)
0 diff
(100 %id)
AW951336   .n 1181 to 1532 352 to 1     Submitted on the opposite strand 352/353
(99 %)
0 diff
(100 %id)
AA582847 germ cell tumor .n 1192 to 1663 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
AW603394 colon_normal .n 1193 to 1396 1 to 207       207/208
(99 %)
18 diff
(91.4 %id)
BF737035 bladder_tumor .n 1200 to 1412 1 to 215       215/215
(100 %)
18 diff
(91.7 %id)
AW250864 lung, small cell carcinoma .n 1206 to 1701 506 to 11   tiling clone, AAA   496/496
(100 %)
0 diff
(100 %id)
BF736598 bladder_tumor .n 1210 to 1415 206 to 1     Submitted on the opposite strand 206/206
(100 %)
1 diff
(99.6 %id)
AA368428 placenta .n 1224 to 1520 301 to 1       301/301
(100 %)
4 diff
(98.7 %id)
AW604042 colon_normal .n 1234 to 1604 393 to 24       370/396
(93 %)
0 diff
(100 %id)
U31214   .n 1254 to 1699 1 to 447   AAA   447/447
(100 %)
6 diff
(98.7 %id)
AA858382 pharynx, squamous cell carcinoma .n 1269 to 1700 434 to 3       432/434
(99 %)
0 diff
(100 %id)
AI002255 carcinoid, lung .n 1273 to 1684 408 to 1       408/408
(100 %)
4 diff
(99.1 %id)
AI281233 adenocarcinoma, colon .n 1315 to 1701 397 to 11   AAA   387/387
(100 %)
1 diff
(99.8 %id)
BE856454 Prostate .n 1331 to 1702 379 to 8       372/379
(98 %)
0 diff
(100 %id)
AI474458 Prostate .n 1335 to 1701 367 to 1       367/367
(100 %)
2 diff
(99.5 %id)
AA397362   .n 1352 to 1702 364 to 13       352/364
(96 %)
0 diff
(100 %id)
AA152426 colon, tumor .n 1379 to 1702 324 to 1   fully sequenced,   324/324
(100 %)
1 diff
(99.7 %id)
FN102264 breast carcinoma .n 1386 to 1471 90 to 7     Submitted on the opposite strand 84/91
(92 %)
0 diff
(100 %id)
AW204212   .n 1387 to 1701 332 to 18   AAA   315/315
(100 %)
4 diff
(98.8 %id)
BQ187840 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 1404 to 1701 1 to 298   AAA   298/298
(100 %)
1 diff
(99.7 %id)
D25720   .n 1432 to 1702 1 to 271   tiling clone, Submitted on the opposite strand 271/273
(99 %)
1 diff
(99.7 %id)
BQ022200 placenta .n 1472 to 1701 247 to 18   AAA   230/230
(100 %)
1 diff
(99.6 %id)
DA891307 rectum .o 1 to 589 2 to 590 exact tiling clone, capped   589/589
(100 %)
0 diff
(100 %id)
BX371629 Placenta Cot 25-normalized .p 1 to 899 900 to 1   tiling clone,   900/900
(100 %)
10 diff
(98.9 %id)
BM789082 Ascites, stomach .p 724 to 1279 1 to 556   tiling clone,   556/556
(100 %)
1 diff
(99.9 %id)
BG982631 colon_normal .p 958 to 1286 1 to 329   tiling clone,   329/329
(100 %)
0 diff
(100 %id)
NM_001136010.1   .q 1 to 759 1 to 759 exact RefSeq,   759/759
(100 %)
0 diff
(100 %id)
DB004949 breast, tumor tissue .q 187 to 736 2 to 551 L39H tiling clone, capped   550/550
(100 %)
3 diff
(99.5 %id)
DB202948 trachea .q 187 to 757 2 to 572 exact capped   571/572
(99 %)
3 diff
(99.5 %id)
DB206593 trachea .q 187 to 767 2 to 582 P36R capped   581/581
(100 %)
4 diff
(99.4 %id)
DA438143 tongue, tumor tissue .q 188 to 759 2 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
DA446897 tongue, tumor tissue .q 188 to 680 2 to 494 L39H capped   493/493
(100 %)
2 diff
(99.6 %id)
DA447951 tongue, tumor tissue .q 188 to 705 2 to 519 L39H capped   518/518
(100 %)
2 diff
(99.7 %id)
DA453717 tongue, tumor tissue .q 188 to 744 2 to 558 exact capped   557/557
(100 %)
1 diff
(99.9 %id)
DA878745 Prostate .q 188 to 750 2 to 564 L39H capped   563/564
(99 %)
3 diff
(99.5 %id)
DB012774 esophageal, tumor tissue .q 188 to 715 2 to 529 exact capped   528/528
(100 %)
1 diff
(99.9 %id)
DB014095 esophageal, tumor tissue .q 188 to 757 2 to 572 exact capped   571/572
(99 %)
2 diff
(99.7 %id)
DA872075 Prostate .q 189 to 705 2 to 518 P36R capped   517/517
(100 %)
2 diff
(99.7 %id)
DB012497 esophageal, tumor tissue .q 189 to 646 2 to 459 P36R capped   458/458
(100 %)
1 diff
(99.8 %id)
BX357351 Placenta Cot 25-normalized .q 220 to 1052 1 to 835 S35I P36R C37X P38X tiling clone,   835/873
(95 %)
39 diff
(95.6 %id)
BF874676 lung_tumor .q 531 to 923 398 to 5   tiling clone, Submitted on the opposite strand 394/412
(95 %)
0 diff
(100 %id)
NM_001136009.1   .r 1 to 843 1 to 843 exact RefSeq,   843/843
(100 %)
0 diff
(100 %id)
AK311689 trachea .r 186 to 1025 1 to 840 Y32N tiling clone,   840/840
(100 %)
4 diff
(99.6 %id)
DB199648 trachea .r 187 to 725 2 to 540 Y32N capped   539/539
(100 %)
3 diff
(99.5 %id)
DA453055 tongue, tumor tissue .r 188 to 747 2 to 561 K3R L39H capped   560/560
(100 %)
4 diff
(99.3 %id)
DA454066 tongue, tumor tissue .r 188 to 786 2 to 600 exact tiling clone, capped   599/599
(100 %)
0 diff
(100 %id)
DA874596 Prostate .s 1 to 567 2 to 568 exact tiling clone, capped   567/568
(99 %)
1 diff
(99.9 %id)
BG474462 eye, retinoblastoma .t 1 to 567 1 to 581 K12N C13M K14Q F15V G16W ... tiling clone,   581/955
(60 %)
24 diff
(97.5 %id)
BQ326463 colon_normal .u-u 1 to 365 372 to 9 exact tiling clone,   364/385
(94 %)
21 diff
(94.6 %id)
BF333517 colon_normal Gene FXYD3, variant not shown              
BF760577 colon Gene FXYD3, variant not shown         This clone was ignored    
DB313042 colon Gene FXYD3, variant not shown              
DA430223 colon Gene FXYD3, variant not shown       capped      
R66638 placenta Gene FXYD3, variant not shown         This clone was ignored    
R67359 placenta Gene FXYD3, variant not shown         This clone was ignored    
AA515800 colon Gene FXYD3, variant not shown         Submitted on the opposite strand    
AI832996 colon Gene FXYD3, variant not shown         This clone was ignored    
BU955169 mixed (pool of 40 RNAs) Gene FXYD3, variant not shown         Suspected internal deletion, this clone was ignored    
CK430336 eye, lacrimal gland Gene FXYD3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI